鈥淐ompletely new diagnostic platform鈥� could prove to be a valuable clinical tool for detecting exposure to multiple viruses.

Researchers in Rochester are developing an optical chip on a disposable card that can detect exposure to multiple viruses within a minute鈥攊ncluding the coronavirus that causes COVID-19鈥攆rom a single drop of blood.
Led by 天美传媒 researcher , the $1.7 million project is funded by the US Department of Defense Manufacturing Technology Program using CARES Act funds through a contract with . The collaboration also involves Ortho Clinical Diagnostics, which develops and manufactures innovative laboratory testing and blood-typing solutions at its Global Center for R&D Excellence in Rochester; Syntec Optics, a maker of polymer optics in Rochester; researchers at the NY CREATES 300mm microelectronics research facility in Albany, New York, and at the University of California at Santa Barbara; and the Naval Research Laboratory in Washington, DC.
鈥淭his is a completely new diagnostic platform,鈥� says Miller, the Dean鈥檚 Professor of Dermatology and a professor of biomedical engineering, optics, and biochemistry and biophysics. 鈥淲e think this is going to be valuable in very broad applications for clinical diagnostics, not just COVID-19.鈥�
Key to the technology is an optical chip, no larger than a grain of rice. Proteins associated with eight different viruses, including SARS-CoV-2, are contained in separate sensor areas of the chip. If someone has been exposed to any of the viruses, antibodies to those viruses in the blood sample will be drawn to the proteins and detected.
Antibodies are proteins produced by the immune system to fight off specific bacteria and viruses. They remain in the immune system even after a patient recovers from an infection.
鈥淚t is exciting to see the sensors work developed by AIM Photonics, over the past five years, now play a part in more effective testing for COVID-19 and future diseases,鈥� says Michael Cumbo, CEO of AIM Photonics. 鈥淭he industry, academic, and government partnership is a fundamental piece of this institute. Together, we foster successful technology developments such as this optical chip, which in turn enables a very innovative diagnostic platform.鈥�
The card will enable clinicians not only to detect and study COVID-19, but also to better understand potential relationships between COVID-19 infection and previous infections and immunity to other respiratory viruses, including circulating coronaviruses that cause the common cold.
鈥淏ut one of the attractive aspects of this is there鈥檚 a pathway for this technology to eventually be used in a doctor鈥檚 office or a pharmacy,鈥� Miller says.
鈥淥ur goal is to have a validated benchtop prototype by this winter, early spring at the latest.鈥�
The researchers will use blood drawn from 100 consenting convalescent COVID-19 patients to test the device鈥檚 effectiveness.
When the researchers complete and validate the initial prototype, they will be able to apply for up to $5.3 million in additional funding to move the technology closer to commercial availability.
Read more
Two Rochester scientists named AAAS fellowsTodd Krauss, professor and chair of the Department of Chemistry, and Benjamin Miller, the Dean鈥檚 Professor of Dermatology, were recognized for their 鈥渆fforts toward advancing scientific applications that are deemed scientifically or socially distinguished.鈥�
Rochester researchers pursue quick ways to detect COVID-19Nanomembranes, optical sensors, and blood analysis: Rochester faculty are turning previous research avenues to focus on ways to quickly detect novel coronavirus to speed treatment.
鈥極rgan on a chip鈥� is the wave of the futureRochester researchers are building technology to predict the course of tendon injuries鈥攁 form of personalized medicine that will lead to more effective treatments.
